← Back to Search

cognitive behavioral treatment of insomnia for Chronic Insomnia

N/A
Waitlist Available
Led By Philip Gehrman, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial will examine whether treating insomnia with cognitive behavioral therapy decreases dementia biomarkers found in cerebrospinal fluid.

Eligible Conditions
  • Chronic Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CSF markers related to dementia

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive behavioral treatment of insomnia (CBT-I)Experimental Treatment1 Intervention
Eight weeks of cognitive behavioral treatment of insomnia.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
cognitive behavioral treatment of insomnia
2019
N/A
~10

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,880,079 Total Patients Enrolled
Philip Gehrman, PhDPrincipal InvestigatorUniversity of Pennsylvania
4 Previous Clinical Trials
157 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being recruited for this investigation?

"Affirmative. Information on clinicaltrials.gov confirms that the trial is currently recruiting, having been first posted in September 2019 and last amended on January 7th 2022. The study requires 15 participants from 1 medical facility to participate."

Answered by AI

What are the primary criteria for recruitment in this clinical trial?

"The study is seeking 15 individuals aged 30 to 50 who are suffering from insomnia. Both genders may participate so long as they meet the previously stated age criteria."

Answered by AI

How many people are contributing to the research effort of this investigation?

"Affirmative. According to the clinicaltrials.gov information, this medical trial is currently recruiting participants after being originally posted on September 1st 2019 and last amended on January 7th 2022. 15 patients need to be found within a single site for completion of enrollment."

Answered by AI

Is this trial open to volunteers who are younger than 65?

"This clinical trial requires that prospective participants are aged between 30 and 50. 42 trials are specifically for younger individuals, while 559 have been established for seniors."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment
2019. "Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04073992.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top